Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials
JCO Precision Oncology · 2024
DOI: 10.1200/po.23.00398 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Jennyfer M García-Cárdenas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Ciencia de Datos Biomédicos, Escuela de Medicina, Facultad de Ciencias Médicas de la Salud y de la Vida, Universidad Internacional del…. Hauptthemen laut MEDLINE: Genomics, Precision Medicine, Clinical Trials as Topic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Ethnic diversity in cancer research is crucial as race/ethnicity influences cancer incidence, survival, drug response, molecular pathways, and epigenetic phenomena. In 2018, we began a project to examine racial/ethnic diversity in cancer research, with a commitment to review these disparities every 4 years. This report is our second assessment, detailing the present state of racial/ethnic diversity in cancer genomics and clinical trials. METHODS To study racial/ethnic inclusion in cancer genomics, we extracted ethnic records from all data sets available at cBioPortal (n = 125,128 patients) and cancer-related genome-wide association studies (n = 28,011,282 patients) between 2018 and 2022. Concerning clinical trials, we selected studies related to breast cancer (n = 125,518 patients, 181 studies), lung cancer (n = 34,329 patients, 119 studies), and colorectal cancer (n = 40,808 patients, 105 studies). RESULTS In cancer genomics (N = 28,136,410), 3% of individuals lack racial/ethnic registries; tumor samples were collected predominantly from White patients (89.14%), followed by Asian (7%), African American (0.55%), and Hispanic (0.21%) patients and other populations (0.1%). In clinical trials (N = 200,655), data on race/ethnicity are missing for 60.14% of the participants; for individuals whose race/ethnicity was recorded, most were characterized as White (28.33%), followed by Asian (7.64%), African (1.79), other ethnicities (1.37), and Hispanic (0.73). Racial/ethnic representation significantly deviates from global ethnic proportions ( P ≤ .001) across all data sets, with White patients outnumbering other ethnic groups by a factor of approximately 4-6. CONCLUSION Our second update on racial/ethnic representation in cancer research highlights the persistent overrepresentation of White populations in cancer genomics and a notable absence of racial/ethnic information across clinical trials. To ensure more equitable and effective precision oncology, future efforts should address the reasons behind the insufficient representation of ethnically diverse populations in cancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratorio de Ciencia de Datos Biomédicos, Escuela de Medicina, Facultad de Ciencias Médicas de la Salud y de la Vida, Universidad Internacional del Ecuador, Quito, Ecuador.
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.
- Department of Medical Oncology, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
- Instituto Nacional de Investigación en Salud Pública, Quito, Ecuador.
- Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
ORCID-Profile: Jennyfer M García-Cárdenas, Alberto Indacochea, David Pesantez-Coronel, Martín Terán-Navas, Ana Aleaga, Isaac Armendáriz-Castillo, Lizbeth Peña Zúñiga, Carla Morán-Erazo, Erik Chávez-Vélez, Andy Pérez-Villa, Andrés López-Cortés, Santiago Guerrero
Zitieren
APA
García-Cárdenas, J. M., Indacochea, A., Pesantez-Coronel, D., Terán-Navas, M., Aleaga, A., Armendáriz-Castillo, I., Peña Zúñiga, L., Morán-Erazo, C., Chávez-Vélez, E., Pérez-Villa, A., López-Cortés, A., & Guerrero, S. (2024). Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials. JCO Precision Oncology. https://doi.org/10.1200/po.23.00398
Vancouver
García-Cárdenas JM, Indacochea A, Pesantez-Coronel D, Terán-Navas M, Aleaga A, Armendáriz-Castillo I, et al. Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials. JCO Precision Oncology. 2024. doi:10.1200/po.23.00398
BibTeX
@article{GarcaCrdenas2024,
author = {García-Cárdenas, Jennyfer M and Indacochea, Alberto and Pesantez-Coronel, David and Terán-Navas, Martín and Aleaga, Ana and Armendáriz-Castillo, Isaac and Peña Zúñiga, Lizbeth and Morán-Erazo, Carla and Chávez-Vélez, Erik and Pérez-Villa, Andy and López-Cortés, Andrés and Guerrero, Santiago},
title = {Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.23.00398}
}
EUVIMED